flu

Combine

Biotech

Osivax bags flu vaccine rights to pursue combination shot vision

The deal positions Osivax to build on early evidence that its midphase candidate complements traditional flu shots.

Nick Paul Taylor Aug 27, 2026 10:00am

predictive analytics

Moderna's next-gen COVID vax surpasses approved version in ph. 3

Mar 26, 2024 10:55am

vials vaccine research vaccines factory manufacturing

Novo Nordisk Foundation sets up $260M vaccine initiative

Dec 18, 2023 11:14am

beach sand footprints water ocean footsteps

Moderna culls 4 clinical assets

Sep 13, 2023 5:58pm

A nurse preparing a medical injection

Moderna's first seasonal flu shot candidate slides into clinic

Jul 7, 2021 10:39am

Janssen culls BARDA-funded flu phase 3 antiviral pimodivir

Sep 3, 2020 7:00am